发明名称 D4 receptor selectivity piperazine derivatives
摘要 Piperazine derivatives of the formula Iin which R1 and R2 have the meanings given in claim 1 are dopamine ligands with a selectivity for the D4 receptor and are suitable for the treatment and prophylaxis of states of anxiety, depression, schizophrenia, obsessions, Parkinson's disease, tardive dyskinesia, nausea and disorders of the gastro-intestinal tract.
申请公布号 US6258813(B1) 申请公布日期 2001.07.10
申请号 US19990254489 申请日期 1999.03.09
申请人 MERCK PATENT GESELLSCHAFT MIT 发明人 ARLT MICHAEL;BOTTCHER HENNING;BARTOSZYK GERD;SEYFRIED CHRISTOPH
分类号 C07D295/02;A61K31/444;A61K31/495;A61K31/496;A61K31/505;A61K31/506;A61P25/00;A61P43/00;C07D213/38;C07D213/74;C07D239/42;C07D241/04;C07D295/04;C07D295/06;C07D295/073;C07D295/096;C07D295/155;C07D307/82;C07D401/12;C07D405/12;C07D409/10;C07D409/12;C07D409/14;(IPC1-7):A61K31/496;C07D401/06;C07D401/14 主分类号 C07D295/02
代理机构 代理人
主权项
地址